Inventiva S.A. (IVA)
NASDAQ: IVA · Real-Time Price · USD
3.160
-0.160 (-4.82%)
At close: Oct 9, 2026, 4:00 PM EDT
3.100
-0.060 (-1.90%)
After-hours: Oct 9, 2026, 7:25 PM EDT
Inventiva Market Cap
Inventiva has a market cap or net worth of $756.65 million as of October 9, 2026. Its market cap has increased by 3.70% in one year.
Market Cap
756.65M
Enterprise Value
726.04M
1-Year Change
3.70%
Global Rank
n/a
Country Rank
n/a
Category
ChartMarket Cap Chart
Since July 10, 2020, Inventiva's market cap has increased from $547.96M to $756.65M, an increase of 38.09%. That is a compound annual growth rate of 5.30%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 756.65M | -14.49% |
| Dec 31, 2025 | 884.84M | 309.83% |
| Dec 31, 2024 | 215.91M | -7.64% |
| Dec 29, 2023 | 233.77M | 16.05% |
| Dec 30, 2022 | 201.44M | -63.07% |
| Dec 31, 2021 | 545.53M | -0.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Apnimed | 771.00M |
| Achieve Life Sciences | 762.51M |
| Annexon | 762.11M |
| Candel Therapeutics | 760.59M |
| Verastem | 758.92M |
| Lexicon Pharmaceuticals | 747.53M |
| Gyre Therapeutics | 746.48M |
| Attovia Therapeutics | 740.01M |